BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bell HN, Rebernick RJ, Goyert J, Singhal R, Kuljanin M, Kerk SA, Huang W, Das NK, Andren A, Solanki S, Miller SL, Todd PK, Fearon ER, Lyssiotis CA, Gygi SP, Mancias JD, Shah YM. Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance. Cancer Cell 2021. [DOI: 10.1016/j.ccell.2021.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Mei S, Deng Z, Chen Y, Ning D, Guo Y, Fan X, Wang R, Meng Y, Zhou Q, Tian X. Dysbiosis: The first hit for digestive system cancer. Front Physiol 2022;13. [DOI: 10.3389/fphys.2022.1040991] [Reference Citation Analysis]
2 Wei M, Wu J, Sun H, Zhang B, Hu X, Wang Q, Li B, Xu L, Ma T, Gao J, Li F, Ling D. An Enzymatic Antibiotic Adjuvant Modulates the Infectious Microenvironment to Overcome Antimicrobial Resistance of Pathogens. Small 2022. [DOI: 10.1002/smll.202205471] [Reference Citation Analysis]
3 Huang J, Mao Y. The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1029033] [Reference Citation Analysis]
4 Dong L, Zhao C, Zhang F, Ma Y, Song C, Penttinen P, Zhang S, Li Z. Metabolic characterization of different-aged Monascus vinegars via HS-SPME-GC-MS and CIL LC-MS approach. LWT 2022. [DOI: 10.1016/j.lwt.2022.114169] [Reference Citation Analysis]
5 Zhang J, Chen X, Zou J, Li C, Kang W, Guo Y, Liu S, Zhao W, Mou X, Huang J, Ke J. MADET: a Manually Curated Knowledge Base for Microbiomic Effects on Efficacy and Toxicity of Anticancer Treatments. Microbiol Spectr 2022;:e0211622. [PMID: 36255293 DOI: 10.1128/spectrum.02116-22] [Reference Citation Analysis]
6 Yangyanqiu W, Shuwen H. Bacterial DNA involvement in carcinogenesis. Front Cell Infect Microbiol 2022;12:996778. [DOI: 10.3389/fcimb.2022.996778] [Reference Citation Analysis]
7 Ivleva EA, Grivennikov SI. Microbiota-driven mechanisms at different stages of cancer development. Neoplasia 2022;32:100829. [PMID: 35933824 DOI: 10.1016/j.neo.2022.100829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu J, Wang S, Yi R, Long X, Zhao X. Effect of Lactobacillus fermentum ZS40 on the NF-κB signaling pathway in an azomethane-dextran sulfate sodium-induced colon cancer mouse model. Front Microbiol 2022;13:953905. [DOI: 10.3389/fmicb.2022.953905] [Reference Citation Analysis]
9 Ramirez Garcia A, Hurley K, Marastoni G, Diard M, Hofer S, Greppi A, Hardt W, Lacroix C, Sturla SJ, Schwab C. Pathogenic and Commensal Gut Bacteria Harboring Glycerol/Diol Dehydratase Metabolize Glycerol and Produce DNA-Reactive Acrolein. Chem Res Toxicol . [DOI: 10.1021/acs.chemrestox.2c00137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yuan H, Xia P, Sun X, Ma J, Xu X, Fu C, Zhou H, Guan Y, Li Z, Zhao S, Wang H, Dai L, Xu C, Dong S, Geng Q, Li Z, Wang J. Photothermal Nanozymatic Nanoparticles Induce Ferroptosis and Apoptosis through Tumor Microenvironment Manipulation for Cancer Therapy. Small. [DOI: 10.1002/smll.202202161] [Reference Citation Analysis]
11 Xu Y, Ding X, Wang Y, Li D, Xie L, Liang S, Zhang Y, Li W, Fu A, Zhan X. Bacterial Metabolite Reuterin Attenuated LPS-Induced Oxidative Stress and Inflammation Response in HD11 Macrophages. Antioxidants 2022;11:1662. [DOI: 10.3390/antiox11091662] [Reference Citation Analysis]
12 Zhou P, Hu Y, Wang X, Shen L, Liao X, Zhu Y, Yu J, Zhao F, Zhou Y, Shen H, Li J. Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy. Front Immunol 2022;13:877939. [DOI: 10.3389/fimmu.2022.877939] [Reference Citation Analysis]
13 Xing C, Du Y, Duan T, Nim K, Chu J, Wang HY, Wang R. Interaction between microbiota and immunity and its implication in colorectal cancer. Front Immunol 2022;13:963819. [DOI: 10.3389/fimmu.2022.963819] [Reference Citation Analysis]
14 Xu L, Liu B, Huang L, Li Z, Cheng Y, Tian Y, Pan G, Li H, Xu Y, Wu W, Cui Z, Xie L. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model. Microbiol Spectr 2022;:e0065722. [PMID: 35730951 DOI: 10.1128/spectrum.00657-22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Bell HN, Das NK, Shah YM. Protocol for isolation and analysis of small volatile microbiome metabolites from human or mouse samples. STAR Protocols 2022;3:101311. [DOI: 10.1016/j.xpro.2022.101311] [Reference Citation Analysis]
16 Zhang J, Chen X, Zou J, Li C, Kang W, Guo Y, Liu S, Zhao W, Mou X, Huang J, Ke J. MADET: A Manually Curated Knowledgebase for Microbiomic Effects on Efficacy and Toxicity of Anticancer Treatments.. [DOI: 10.1101/2022.05.23.493174] [Reference Citation Analysis]
17 Ma Y, Qu R, Zhang Y, Jiang C, Zhang Z, Fu W. Progress in the Study of Colorectal Cancer Caused by Altered Gut Microbiota After Cholecystectomy. Front Endocrinol 2022;13:815999. [DOI: 10.3389/fendo.2022.815999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Watschinger C, Moschen AR. Lactobacillus reuteri-an old acquaintance takes on a new task in colorectal tumor surveillance. Cancer Cell 2022;40:125-7. [PMID: 35167822 DOI: 10.1016/j.ccell.2022.01.014] [Reference Citation Analysis]
19 Abouloifa H, Hasnaoui I, Rokni Y, Bellaouchi R, Ghabbour N, Karboune S, Brasca M, Abousalham A, Jaouadi B, Saalaoui E, Asehraou A. Antifungal activity of lactic acid bacteria and their application in food biopreservation. Advances in Applied Microbiology 2022. [DOI: 10.1016/bs.aambs.2022.07.001] [Reference Citation Analysis]